Cargando…

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

INTRODUCTION: Immunological protection against human immunodeficiency virus-1 (HIV-1) infection is likely to require both humoral and cell-mediated immune responses, the latter involving cytotoxic CD8 T-cells. Characterisation of CD8 T-cell mediated direct anti-viral activity would provide understan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Natalia, Hayes, Peter, Makinde, Julia, Hare, Jonathan, King, Deborah, Xu, Rui, Rehawi, Ola, Mezzell, Allison T., Kato, Laban, Mugaba, Susan, Serwanga, Jennifer, Chemweno, James, Nduati, Eunice, Price, Matt A., Osier, Faith, Ochsenbauer, Christina, Yue, Ling, Hunter, Eric, Gilmour, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751811/ https://www.ncbi.nlm.nih.gov/pubmed/36532063 http://dx.doi.org/10.3389/fimmu.2022.1029029

Ejemplares similares

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set
por: Hayes, Peter, et al.
Publicado: (2021)

Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
por: Balinda, Sheila N., et al.
Publicado: (2022)

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses
por: Luthuli, Bonisile, et al.
Publicado: (2023)

Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells
por: Ochiel, Daniel O., et al.
Publicado: (2010)

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
por: Stoddard, Mark B., et al.
Publicado: (2015)

Foundered
por: Hayes, P. H.
Publicado: (1876)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo
por: Merbah, Melanie, et al.
Publicado: (2012)

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2009)

A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection
por: Makinde, Julia, et al.
Publicado: (2021)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
por: Ananthaswamy, Neeti, et al.
Publicado: (2019)

Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
por: Nijmeijer, Bernadien M., et al.
Publicado: (2019)

HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses
por: Lumngwena, Evelyn Ngwa, et al.
Publicado: (2020)

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains
por: Lucas, Julie, et al.
Publicado: (2023)

Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner
por: Frange, Pierre, et al.
Publicado: (2013)

Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles()
por: Serwanga, Jennifer, et al.
Publicado: (2015)

Taillessness in a Cloned Cow is Not Genetically Transmitted
por: Wagner, Stefan, et al.
Publicado: (2017)

A deeper view of transmitted/founder viruses using 454 whole genome deep sequencing
por: Tully, DC, et al.
Publicado: (2012)

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome
por: Song, Hongshuo, et al.
Publicado: (2012)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2016)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
por: Hertoghs, Nina, et al.
Publicado: (2019)

Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques
por: Bauer, Anya, et al.
Publicado: (2023)

Cloning of the Herpes smplex virus Type 1 genome as an novel luciferase infectious bacterial artificial chromosome
por: Li, You, et al.
Publicado: (2011)

P16-03. Persistence of robust cross-reactive group M consensus T-cell responses in a chronic HIV-1 clade A1 and D-infected Ugandan population
por: Serwanga, JJ, et al.
Publicado: (2009)

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
por: Goonetilleke, Nilu, et al.
Publicado: (2009)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Relative resistance of HIV-1 founder viruses to control by interferon-alpha
por: Fenton-May, Angharad E, et al.
Publicado: (2013)

P20-10. Differences in patterns of Gag-induced immunogenetic pressure occur between clades A and D chronic HIV-1 infection in a Ugandan population
por: Serwanga, J, et al.
Publicado: (2009)

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Rectal Transmission of Transmitted/Founder HIV-1 Is Efficiently Prevented by Topical 1% Tenofovir in BLT Humanized Mice
por: Chateau, Morgan L., et al.
Publicado: (2013)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
por: Podgorski, Rachel M., et al.
Publicado: (2023)

Cloning and mutagenetic modification of the firefly luciferase gene and its use for bioluminescence microscopy of engrailed expression during Drosophila metamorphosis
por: Ogoh, Katsunori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5g9bo7656jt4m0j1jpuj2riff7